GNAO1 Natural History Study

NCT04950946 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-07-06

No results posted yet for this study

Summary

The purpose of the GNAO1 Natural History Study is to establish the clinical phenotype of GNAO1 associated neurologic disease, its association with genotype, and areas of clinical importance within the disease.

Conditions

  • GNAO1

Sponsors & Collaborators

  • The Bow Foundation

    collaborator UNKNOWN
  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Amy Viehoever, MD, Ph.D. · Washington University School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04950946 on ClinicalTrials.gov